Braxia Scientific (BRAXF) Ratios

111 Followers

Braxia Scientific Ratios

BRAXF's free cash flow for Q2 2024 was C$0.22. For the 2024 fiscal year, BRAXF's free cash flow was decreased by C$ and operating cash flow was C$-0.42. See a summary of the company’s cash flow.

Ratios	TTM	Jun 23	Jun 22	Jun 21
Liquidity Ratios
Current Ratio	―	1.00	3.81	4.47
Quick Ratio	―	1.00	3.81	4.47
Cash Ratio	―	0.68	3.42	4.35
Solvency Ratio	―	-5.52	-4.53	-34.15
Operating Cash Flow Ratio	―	-3.44	-1.78	-1.98
Short-Term Operating Cash Flow Coverage	―	-148.08	-90.43	-101.19
Net Current Asset Value	C$ ―	C$ -123.75K	C$ 6.99M	C$ 8.80M
Leverage Ratios
Debt-to-Assets Ratio	―	0.05	0.02	<0.01
Debt-to-Equity Ratio	―	0.13	0.02	<0.01
Debt-to-Capital Ratio	―	0.11	0.02	<0.01
Long-Term Debt-to-Capital Ratio	―	0.03	<0.01	<0.01
Financial Leverage Ratio	―	2.42	1.30	1.16
Debt Service Coverage Ratio	―	-185.46	-220.36	-1.66K
Interest Coverage Ratio	―	-419.27	-1.44K	-3.23K
Debt to Market Cap	―	0.02	<0.01	<0.01
Interest Debt Per Share	―	<0.01	<0.01	<0.01
Net Debt to EBITDA	―	0.10	0.70	0.12
Profitability Margins
Gross Profit Margin	―	9.12%	16.60%	14.45%
EBIT Margin	―	-704.27%	-818.64%	-8808.74%
EBITDA Margin	―	-675.17%	-816.82%	-8769.58%
Operating Profit Margin	―	-397.00%	-479.42%	-1043.84%
Pretax Profit Margin	―	-705.22%	-818.97%	-8809.07%
Net Profit Margin	―	-697.48%	-815.93%	-8809.07%
Continuous Operations Profit Margin	―	-697.48%	-815.93%	-8771.75%
Net Income Per EBT	―	98.90%	99.63%	100.00%
EBT Per EBIT	―	177.64%	170.83%	843.91%
Return on Assets (ROA)	―	-338.34%	-104.29%	-480.41%
Return on Equity (ROE)	―	-818.94%	-135.39%	-559.04%
Return on Capital Employed (ROCE)	―	-430.88%	-78.38%	-66.04%
Return on Invested Capital (ROIC)	―	-408.30%	-77.38%	-65.80%
Return on Tangible Assets	―	-435.72%	-122.99%	-776.04%
Earnings Yield	―	-230.13%	-115.40%	-63.31%
Efficiency Ratios
Receivables Turnover	―	4.61	1.83	8.89
Payables Turnover	―	1.57	1.88	0.44
Inventory Turnover	―	197.35	0.00	0.00
Fixed Asset Turnover	―	2.30	8.83	20.02
Asset Turnover	―	0.49	0.13	0.05
Working Capital Turnover Ratio	―	0.53	0.19	0.21
Cash Conversion Cycle	―	-151.56	4.71	-794.85
Days of Sales Outstanding	―	79.22	199.05	41.06
Days of Inventory Outstanding	―	1.85	0.00	0.00
Days of Payables Outstanding	―	232.63	194.34	835.91
Operating Cycle	―	81.07	199.05	41.06
Cash Flow Ratios
Operating Cash Flow Per Share	―	-0.03	-0.03	-0.03
Free Cash Flow Per Share	―	-0.04	-0.03	-0.03
CapEx Per Share	―	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	―	1.12	1.01	1.00
Dividend Paid and CapEx Coverage Ratio	―	-8.20	-179.23	-230.47
Capital Expenditure Coverage Ratio	―	-8.20	-179.23	-230.47
Operating Cash Flow Coverage Ratio	―	-35.72	-20.82	-47.01
Operating Cash Flow to Sales Ratio	―	-3.93	-3.04	-5.01
Free Cash Flow Yield	―	-145.37%	-43.21%	-3.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-0.43	-0.87	-1.58
Price-to-Sales (P/S) Ratio	―	3.03	7.07	139.13
Price-to-Book (P/B) Ratio	―	3.56	1.17	8.83
Price-to-Free Cash Flow (P/FCF) Ratio	―	-0.69	-2.31	-27.63
Price-to-Operating Cash Flow Ratio	―	-0.77	-2.33	-27.75
Price-to-Earnings Growth (PEG) Ratio	―	0.03	<0.01	>-0.01
Enterprise Value Multiple	―	-0.35	-0.17	-1.46
Enterprise Value	―	4.46M	2.05M	129.31M
EV to EBITDA	―	-0.35	-0.17	-1.46
EV to Sales	―	2.36	1.38	128.23
EV to Free Cash Flow	―	-0.54	-0.45	-25.46
EV to Operating Cash Flow	―	-0.60	-0.45	-25.57
Tangible Book Value Per Share	―	<0.01	0.04	0.06
Shareholders’ Equity Per Share	―	<0.01	0.05	0.10
Tax and Other Ratios
Effective Tax Rate	―	0.01	<0.01	>-0.01
Revenue Per Share	―	<0.01	<0.01	<0.01
Net Income Per Share	―	-0.06	-0.07	-0.56
Tax Burden	―	0.99	1.00	1.00
Interest Burden	―	1.00	1.00	1.00
Research & Development to Revenue	―	0.05	0.13	1.96
SG&A to Revenue	―	2.90	4.65	6.78
Stock-Based Compensation to Revenue	―	0.46	1.63	3.07
Income Quality	―	0.56	0.37	0.06

Currency in CAD